文献速递肿瘤 PET/CT

18F-FDG PET/CT对既往肿瘤患者孤立性与多发性肺结节的诊断效能:182个结节报告

18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-12-08

该回顾性研究评估了18F-FDG PET/CT在148例既往肿瘤患者随访中检出的182个肺结节(121个孤立、61个多发)的诊断效能。恶性患病率为75.8%,视觉分析灵敏度79%、特异度81.8%、准确率79.7%,ROC分析SUVmax cut-off=1.7时灵敏度85.5%、特异度72.7%。孤立性结节恶性患病率87.6%且诊断效能更好,多发性结节患病率52.5%。

要点

  • 既往肿瘤患者肺结节恶性患病率高(75.8%),PET/CT阳性预测值达93.1%,利于「rule in」恶性。
  • 孤立性结节诊断效能优于多发性结节,恶性患病率87.6% vs 52.5%,NPV在孤立性结节中仅36.7%。
  • 恶性结节多见于男性、孤立性模式及上叶,且尺寸和代谢活性(SUVmax、TLG)显著高于良性结节。

核心结论

  • 在既往肿瘤患者随访中,18F-FDG PET/CT对肺结节恶性诊断具有良好效能,尤其适用于孤立性结节,即使尺寸较小也能较好排除或提示恶性。
  • 多发性结节模式下PET有助于个体化管理,识别需要组织学评估的「参考」结节。

研究设计与样本

  • 回顾性研究,纳入148例既往肿瘤患者(89例男性,平均年龄69.5±8.4岁)的182个肺结节(121个孤立,61个多发;平均大小16.5±8.1 mm,平均SUVmax 5.2±5.1)。
  • 最终诊断由组织学或影像学随访确立,评估18F-FDG视觉分析(恶性标准:摄取≥纵隔活性)、SUVmax的ROC曲线分析及结节特征。

主要发现

  • 182个结节中恶性患病率75.8%,PET/CT视觉分析灵敏度79%、特异度81.8%、准确率79.7%、PPV 93.1%、NPV 55.4%,ROC分析SUVmax cut-off=1.7时灵敏度85.5%、特异度72.7%。
  • 121个孤立结节中恶性患病率87.6%,PET/CT灵敏度82.1%、特异度73.3%、准确率81%、PPV 95.6%、NPV 36.7%,ROC分析SUVmax cut-off=2时灵敏度84%、特异度80%。
  • 61个多发结节中恶性患病率52.5%,结节水平与患者水平分析:灵敏度68.7%和88.9%,特异度86.2%和55.6%,准确率77%和77.8%,PPV 84.4%和80%,NPV 71.8%和71.5%;结节水平ROC分析SUVmax cut-off=1.8时灵敏度71.9%、特异度82.8%。
  • 恶性结节多见于男性、孤立性模式及上叶,尺寸和代谢活性(SUVmax和TLG)显著高于良性结节,而与前次肿瘤诊断至结节检出间隔时间、患者年龄或其他结节特征(肺侧、中央/外周)无差异。
  • 无论孤立性还是多发性模式,恶性结节的尺寸和代谢活性均显著高于良性结节。

关键数值与推荐

  • 视觉分析恶性标准:结节摄取≥纵隔活性。
  • 全部182个结节ROC分析SUVmax cut-off=1.7,灵敏度85.5%、特异度72.7%。
  • 孤立性结节ROC分析SUVmax cut-off=2,灵敏度84%、特异度80%。
  • 多发性结节结节水平ROC分析SUVmax cut-off=1.8,灵敏度71.9%、特异度82.8%。

临床怎么用

  • 对既往肿瘤患者随访中检出的肺结节,18F-FDG PET/CT可用于支持恶性诊断(尤其孤立性结节),但阴性结果需谨慎解读,NPV在孤立性结节中仅36.7%。
  • 多发性结节中PET可帮助识别代谢活性最高的「参考」结节,指导个体化活检决策。
  • 恶性结节与男性、孤立性模式、上叶分布及更高的SUVmax和TLG相关,可辅助风险分层。

局限性

  • 回顾性研究设计。
  • 样本来自单中心148例患者182个结节。
  • 最终诊断部分依赖影像学随访而非全部组织学确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In oncological patients, 18F-FDG PET/CT performance for pulmonary nodules' characterization is not well-established. Thus, the purpose of this study was to evaluate the 18F-FDG PET/CT diagnostic performance in pulmonary nodules detected during follow-up in oncological patients and the relationship between malignancy and nodules' characteristics. METHODS: We retrospectively evaluated 182 pulmonary nodules (121 solitary, 61 multiple; mean size = 16.5 ± 8.1 mm, mean SUVmax = 5.2 ± 5.1) in 148 oncological patients (89 males; mean age = 69.5 ± 8.4 years). Final diagnosis was established by histology or radiological follow-up. Diagnostic performance of 18F-FDG visual analysis (malignancy-criterion: uptake ≥ mediastinal activity), ROC curve analysis for SUVmax and nodules' characteristics were assessed. RESULTS: In 182 nodules, the prevalence of malignancy was 75.8%; PET/CT provided sensitivity = 79%, specificity = 81.8%, accuracy = 79.7%, PPV = 93.1%, NPV = 55.4%; ROC analysis (SUVmax cut-off = 1.7) provided sensitivity = 85.5%, specificity = 72.7%. In 121 solitary nodules, the prevalence of malignancy was 87.6%; PET/CT provided sensitivity = 82.1%, specificity = 73.3%, accuracy = 81%, PPV = 95.6%, NPV = 36.7%; ROC analysis (SUVmax cut-off = 2) provided sensitivity = 84%, specificity = 80%. In 61 multiple nodules, the prevalence of malignancy was 52.5%; PET/CT (nodule and patient-based analysis, respectively) provided sensitivity = 68.7% and 88.9%, specificity = 86.2% and 55.6%, accuracy = 77% and 77.8%, PPV = 84.4% and 80%, NPV = 71.8% and 71.5%; ROC analysis (nodule-based, SUVmax cut-off = 1.8) provided sensitivity = 71.9%, specificity = 82.8%. Malignant nodules were prevalent in males, in solitary pattern and in upper lobes, and had significantly greater size and metabolic activity (SUVmax and TLG) than benign ones, with no differences in interval-time between previous cancer diagnosis and nodule detection, patients' age or other nodules' features (lung side, central/peripheral). When comparing solitary and multiple patterns, malignant nodules had significantly greater size and metabolic activity than benign ones in both groups. CONCLUSIONS: In oncological patients, 18F-FDG PET/CT provides good diagnostic performance for ruling in the malignancy in pulmonary nodules detected during follow-up, even at small size and especially when solitary. In multiple patterns, PET seems useful in the perspective of a personalized management, for identifying the "reference" nodule deserving histological assessment.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Taralli S, Scolozzi V, Foti M, et al. 18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules. Eur J Nucl Med Mol Imaging. 2018. PMID: 30535767. doi:10.1007/s00259-018-4226-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。